Nasdaq:US$13.41 (-0.23) | HKEX:HK$20.95 (-0.20) | AIM:£2.16 (-0.05)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

1 items
a070702